Skip to main content
. 2018 Apr 2;15(6):4683–4688. doi: 10.3892/etm.2018.6024

Figure 2.

Figure 2.

Percentage changes of total C, HDL-C and triglycerides from baseline after eight weeks of treatment. Patients in the statin/col and statin/eze groups achieved higher percentages of total C reduction compared with those in the statin monotherapy group. Reductions of HDL-C and triglycerides were similar among the three groups. Values are expressed as the ± standard error of the mean (n=60). *P=0.043 and #P=0.035 vs. statin mono group. total C, total cholesterol; HDL-C, high-density lipoprotein cholesterol; col, colesevelam; eze, ezetimibe; mono, monotherapy.